P. Shintaku

发表

Comparison of benign keratoses using p53, bcl‐1, and bcl‐2

C. Ko, S. Binder, P. Shintaku, 2005, Journal of cutaneous pathology.

Immunohistochemical analysis of lung carcinomas with pure or partial bronchioloalveolar differentiation.

M. Fishbein, D. Gui, Longsheng Hong, 2004, Archives of pathology & laboratory medicine.

Novel kidney cancer immunotherapy based on the granulocyte-macrophage colony-stimulating factor and carbonic anhydrase IX fusion gene.

R. Figlin, A. Belldegrun, C. Tso, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Novel 20‐epi‐vitamin D3 analog combined with 9‐cis‐retinoic acid markedly inhibits colony growth of prostate cancer cells

D. Heber, M. Campbell, L. Binderup, 1999, The Prostate.

Induction of G 250-targeted and T-Cell-mediated Antitumor Activity against Renal Cell Carcinoma Using a Chimeric Fusion Protein Consisting of G 250 and Granulocyte / Monocyte-Colony Stimulating Factor

R. Figlin, A. Belldegrun, A. Zisman, 2001 .

Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.

R. Figlin, A. Belldegrun, A. Zisman, 2001, Cancer research.

Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells.

A. Ribas, L. Butterfield, W. McBride, 2000, Cancer research.

Leu-22: a preferential marker for T-lymphocytes in paraffin sections. Staining profile in T- and B-cell lymphomas, Hodgkin's disease, other lymphoproliferative disorders, myeloproliferative diseases, and various neoplastic processes.

G. Pinkus, J. Said, J. Butmarc, 1989, American journal of clinical pathology.

Mucinous Adenocarcinomas of the Thymus: Report of 2 Cases and Review of the Literature

R. Cameron, M. Fishbein, T. Baruch-Oren, 2007, The American journal of surgical pathology.

Primary Glioblastomas Express Mesenchymal Stem-Like Properties

Koji Yoshimoto, Paul S Mischel, Timothy F Cloughesy, 2006, Molecular Cancer Research.

Immunoperoxidase Staining for C4d on Paraffin-embedded Tissue in Cardiac Allograft Endomyocardial Biopsies: Comparison to Frozen Tissue Immunofluorescence

M. Fishbein, J. Qiao, J. Kobashigawa, 2004, Applied immunohistochemistry & molecular morphology : AIMM.

Her‐2/neu Gene Amplification in Low to Moderately Expressing Breast Cancers: Possible Role of Chromosome 17/Her‐2/neu Polysomy

P. N. Rao, S. Bose, M. Mohammed, 2001, The breast journal.

Expression in Malignant Lymphomas

J. Said, P. Shintaku, H. Nakamura, 2007 .

Virilization in bilateral macronodular adrenal hyperplasia controlled by luteinizing hormone.

M. Goodarzi, A. V. Van Herle, D. Dawson, 2003, The Journal of clinical endocrinology and metabolism.

Programmed death-ligand 1 (PD-L1) is expressed in a significant number of the uterine cervical carcinomas

Opal L. Reddy, N. Moatamed, P. Shintaku, 2017, Diagnostic Pathology.

Experimental immunogenic rubeosis iridis.

B. Straatsma, A. Kreiger, P. Shintaku, 1977, Investigative ophthalmology & visual science.

Renal clear-cell carcinoma: an ultrastructural study on the junctional complexes.

A. Rajasekaran, G. Thomas, E. Landaw, 2005, Histology and histopathology.

Human chorionic gonadotropin expression in lung, breast, and renal carcinomas.

G. Braunstein, J. Said, P. Shintaku, 1988, Archives of pathology & laboratory medicine.

Evaluation of PAX8 Expression in Brain Tissue and Related Neoplasms

N. Moatamed, N. Khanlou, P. Shintaku, 2016, Applied immunohistochemistry & molecular morphology : AIMM.

Original Article Unlike prostate, ERG is not expressed in endometrial lesions

N. Moatamed, M. Wadehra, P. Sullivan, 2016 .

Prostate stem cell antigen expression is associated with gleason score, seminal vesicle invasion and capsular invasion in prostate cancer.

S. Horvath, D. Seligson, J. Said, 2004, The Journal of urology.

Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death-ligand 1 (PD-L1), in female breast carcinomas

N. Moatamed, P. Shintaku, A. Kassardjian, 2018, PloS one.

An infant with MLH3 variants, FOXG1‐duplication and multiple, benign cranial and spinal tumors: A clinical exome sequencing study

Joshua L. Deignan, W. Grody, S. Kantarci, 2016, Genes, chromosomes & cancer.

Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer

S. Memarzadeh, S. Reddy, R. Farias-Eisner, 2002, Proceedings of the National Academy of Sciences of the United States of America.

LABAZ1: A metastatic tumor model for renal cell carcinoma expressing the carbonic anhydrase type 9 tumor antigen.

A. Belldegrun, N. Rao, S. Gambhir, 2003, Cancer research.

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice.

H P Koeffler, D. Heber, E. Williamson, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Malignant melanoma with neural differentiation: an exceptional case report and brief review of the pertinent literature.

S. Dry, J. Said, S. Binder, 2014, The American Journal of dermatopathology.

Has the 2004 revision of the International Society of Heart and Lung Transplantation grading system improved the reproducibility of the diagnosis and grading of cardiac transplant rejection?

William D Wallace, M. Fishbein, W. Wallace, 2009, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.